乳がん治療開始スケールの決定因子の開発と検証
Walaa R Almallah1,2, Tamilyn Bakas3, Elizabeth Shaughnessy4
1College of Nursing, University of Cincinnati, Cincinnati, OH, USA almallwr@mail.uc.edu.
Research and theory for nursing practice
|February 14, 2026
まとめ
新しいスケールである乳がん治療開始の決定因子 (DBCTI) スケールは,適切な乳がん治療に影響を与える健康的な信念とヒントを測定するために開発されました. このツールは,早期介入の障壁を特定し,取り除くのに役立ちます.
科学分野:
- 腫瘍学 腫瘍学
- 健康心理学 心理学について
- サイコメトリクス サイコメトリクス
背景:
- 乳がんの治療を早期に開始することは,患者の予後を改善するために非常に重要です.
- 健康信念モデル (Health Belief Model) は,信念と行動へのヒントを通して,健康行動を説明します.
- 乳がんの治療開始に影響を与える要因を評価するために,検証されたスケールが必要です.
研究 の 目的:
- 乳がん治療開始の決定因子 (DBCTI) スケールの開発と検証.
- DBCTIスケールのアイテム開発,コンテンツの妥当性,顔の妥当性を評価する.
- 早期乳がん治療の障壁を理解し,克服するためのツールを提供すること.
主な方法:
- 以前の定性研究に基づくアイテム生成.
- 8人の主題専門家によって評価されたコンテンツ有効性指数 (CVI).
- 5人の乳がん患者によって評価された顔の有効性.
主要な成果:
- DBCTIスケールは77項目で構成され,全体のCVIは0.97.
- サブスケールのCVIは,0.93から0.99の範囲で,強力な有効性を示しています.
- 概念的な重要性からCVIが低いにもかかわらず,2つの項目が保持されました.
結論:
- DBCTIスケールは,強固なコンテンツと顔の有効性を示しています.
- DBCTIスケールについては,さらなる心理測定が推奨されます.
- このスケールは,乳がんの早期治療開始を促進するための臨床評価と介入を導くことができます.
関連する概念動画
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
pH Scale
80.6K
Hydronium and hydroxide ions are present both in pure water and in all aqueous solutions, and their concentrations are inversely proportional as determined by the ion product of water (Kw). The concentrations of these ions in a solution are often critical determinants of the solution’s properties and the chemical behaviors of its other solutes. Two different solutions can differ in their hydronium or hydroxide ion concentrations by a million, billion, or even trillion times. A common means of...
80.6K
Initiation of Translation
39.3K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.3K
Initiation of Translation
8.2K
8.2K
Reliability and Validity
14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
In Vitro Drug Release Testing: Overview, Development and Validation
374
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
374


